Effect of perioperative antibiosis on the postoperative outcome in percutaneous nephrolithopaxia

Effect of perioperative antibiosis on the postoperative outcome in percutaneous nephrolithopaxia - APEROL

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026829

Enrollment

200

Registered

2021-12-06

Start date

2021-06-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of urinary tract infections through stone remediation using percutaneous nephrolithopaxia.

Interventions

Group 1: Patients on antibiotic prophylaxis before PNL Group 2: Patients without antibiotic prophylaxis before PNL Group 3: -

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patient = 18 years, indication for unilateral stone restoration using PNL

Exclusion criteria

Exclusion criteria: Urinary tract anamolia such as: urinary diversion with ileum neobladder, pouch, ileum conduit, ureteral fistula, or similar; Horseshoe kidney; Dystopic kidney position (pelvic kidney); Non-drug coagulation disorder; Taking immunosuppressants

Design outcomes

Primary

Measure	Time frame
Postoperative fever, perioperative complications according to Clavien-Dindo, postoperative antibiosis	—

Secondary

Measure	Time frame
Pre- / intraoperative antibiosis, length of inpatient stay postoperatively, stone-free rate, Secondary interventions within 90 days postoperatively	—

Countries

Germany

Contacts

Public ContactMarco Schnabel

Caritaskrankenhaus St. Josef Regenburg

mschnabel@caritasstjosef.de0941 7820

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026